160 related articles for article (PubMed ID: 22832574)
1. Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma.
Uzawa K; Baba T; Uchida F; Yamatoji M; Kasamatsu A; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
Oncotarget; 2012 Jul; 3(7):670-7. PubMed ID: 22832574
[TBL] [Abstract][Full Text] [Related]
2. Quantitative detection of circulating tumor-derived mitochondrial NADH subunit variants as a potential prognostic biomarker for oral cancer.
Uzawa K; Kasamatsu A; Baba T; Kimura Y; Nakashima D; Higo M; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H
Int J Oncol; 2015 Sep; 47(3):1077-83. PubMed ID: 26179426
[TBL] [Abstract][Full Text] [Related]
3. Mutations in circulating mitochondrial DNA: Cassandra of oral cancer?
Kandel ES
Oncotarget; 2012 Jul; 3(7):664-5. PubMed ID: 22837433
[TBL] [Abstract][Full Text] [Related]
4. Impact of somatic mutations in the D-loop of mitochondrial DNA on the survival of oral squamous cell carcinoma patients.
Lin JC; Wang CC; Jiang RS; Wang WY; Liu SA
PLoS One; 2015; 10(4):e0124322. PubMed ID: 25906372
[TBL] [Abstract][Full Text] [Related]
5. Cell-free mitochondrial DNA copy number variation in head and neck squamous cell carcinoma: A study of non-invasive biomarker from Northeast India.
Kumar M; Srivastava S; Singh SA; Das AK; Das GC; Dhar B; Ghosh SK; Mondal R
Tumour Biol; 2017 Oct; 39(10):1010428317736643. PubMed ID: 29072129
[TBL] [Abstract][Full Text] [Related]
6. Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma.
Kloss-Brandstätter A; Weissensteiner H; Erhart G; Schäfer G; Forer L; Schönherr S; Pacher D; Seifarth C; Stöckl A; Fendt L; Sottsas I; Klocker H; Huck CW; Rasse M; Kronenberg F; Kloss FR
PLoS One; 2015; 10(8):e0135643. PubMed ID: 26262956
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
[TBL] [Abstract][Full Text] [Related]
8. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations in the D-loop of mitochondrial DNA in oral squamous cell carcinoma.
Liu SA; Jiang RS; Chen FJ; Wang WY; Lin JC
Eur Arch Otorhinolaryngol; 2012 Jun; 269(6):1665-70. PubMed ID: 22020698
[TBL] [Abstract][Full Text] [Related]
10. Somatic Mitochondrial Mutations in Oral Cavity Cancers among Senegalese Patients.
Toure S; Mbaye F; Gueye MD; Fall M; Dem A; Lamy JB; Sembene M
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2203-2208. PubMed ID: 31350985
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma.
Hamana K; Uzawa K; Ogawara K; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Br J Cancer; 2005 Jun; 92(12):2181-4. PubMed ID: 15928666
[TBL] [Abstract][Full Text] [Related]
12. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
[TBL] [Abstract][Full Text] [Related]
14. MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma.
Elahi M; Rakhshan V
Sci Rep; 2020 May; 10(1):8475. PubMed ID: 32439976
[TBL] [Abstract][Full Text] [Related]
15. Decreased mitochondrial copy numbers in oral squamous cell carcinoma.
Takeda D; Hasegawa T; Ueha T; Sakakibara A; Kawamoto T; Minamikawa T; Sakai Y; Komori T
Head Neck; 2016 Aug; 38(8):1170-5. PubMed ID: 27079936
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA levels in blood and tissue samples from breast cancer patients of different stages.
Xia P; Wang HJ; Geng TT; Xun XJ; Zhou WJ; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(3):1339-44. PubMed ID: 24606462
[TBL] [Abstract][Full Text] [Related]
17. Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.
Kohler C; Radpour R; Barekati Z; Asadollahi R; Bitzer J; Wight E; Bürki N; Diesch C; Holzgreve W; Zhong XY
Mol Cancer; 2009 Nov; 8():105. PubMed ID: 19922604
[TBL] [Abstract][Full Text] [Related]
18. [Screening of the gene mutation in D-loop region of mitochondrial DNA in oral squamous cell carcinoma].
Sun Y; Yuan RT; Chen WT; Bu LX; Jia MY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 May; 48(5):285-7. PubMed ID: 24004624
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of mitochondrial DNA deletions in human oral tissues -- effects of betel quid chewing and oral cancer.
Lee HC; Yin PH; Yu TN; Chang YD; Hsu WC; Kao SY; Chi CW; Liu TY; Wei YH
Mutat Res; 2001 Jun; 493(1-2):67-74. PubMed ID: 11516716
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study.
Nakashima H; Yoshida R; Hirosue A; Kawahara K; Sakata J; Arita H; Yamamoto T; Toya R; Murakami R; Hiraki A; Shinohara M; Ito T; Kuwahara Y; Nakayama H
Tumour Biol; 2019 Mar; 41(3):1010428319826853. PubMed ID: 30887897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
